ARTICLE | Company News
OXB acquires RAR beta 2 gene
February 5, 2001 8:00 AM UTC
Oxford BioMedica (LSE:OXB) licensed from King's College (London, U.K.) the retinoic acid receptor (RAR) beta 2 gene, which is associated with nerve regeneration. OXB intends to combine its LentiVector...